This core protocol for ECDC studies of VE against hospitalisation with SARI laboratory-confirmed with SARS-CoV-2 or with influenza, version 3.0, represents an update to the main elements for a multi-country hospital-based study of COVID-19 vaccine effectiveness in patients hospitalised with SARI, initially published as version 1.0 [5], updated to version 2.0 [6].
This document proposes an updated strategy for COVID-19 surveillance at national and EU/EEA level that specifically aims to reconcile the data needs for effective pandemic response with what is still feasible in countries and within healthcare systems under siege, while taking into account guidance issued by the World Health Organization.
The European Centre for Disease Prevention and Control (ECDC) and the European Medicines Agency (EMA) have issued a joint statement (link) providing updated public health considerations on the use of the newly authorised adapted COVID-19 vaccines to support the planning of the autumn and winter vaccination campaigns.
This Reporting Protocol provides guidelines for data managers in reporting countries on how to prepare data for submission to TESSy, deadlines for reporting, subject-specific information (e.g. new changes to metadata), and links to further information.
This publication offers practical guidance to EU/EEA countries, encouraging them to transition from emergency surveillance for COVID-19 to more sustainable, objective-driven, surveillance systems.
Yewande Alimi, One Health Unit Lead at Africa CDC and key expert in the ‘EU for Health Security in Africa: ECDC for Africa CDC’ project, shares insights on addressing climate change and infectious diseases in Africa.